These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15462507)

  • 1. Excellent outcome following transplantation of a domino donor liver with high-grade macrosteatosis.
    Azabdaftari G; Pomfret EA; Simpson MA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD; Khettry U
    Pathol Res Pract; 2004; 200(7-8):581-7; discussion 589-90. PubMed ID: 15462507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
    Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A
    Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5.
    Han S; Kwon JH; Lee KW; Lee S; Choi GS; Kim JM; Ko JS; Gwak MS; Kim GS; Ha SY; Joh JW
    Sci Rep; 2023 Aug; 13(1):12914. PubMed ID: 37558742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential Protocol Biopsies Post-Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat?
    Croome KP; Livingston D; Croome S; Keaveny AP; Taner CB; Nakhleh R
    Liver Transpl; 2021 Feb; 27(2):248-256. PubMed ID: 32779325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
    Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
    Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.
    Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS
    Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to the rational use of steatotic donor livers in liver transplantation.
    Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
    Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
    Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsteatosis may not interact with macrosteatosis in living donor liver transplantation.
    Han S; Ha SY; Park CK; Joh JW; Kwon CH; Kwon GY; Kim G; Gwak MS; Jeong WK; Ko JS
    J Hepatol; 2015 Mar; 62(3):556-62. PubMed ID: 25450710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding postmortem donor pool using steatotic liver grafts: a new look.
    Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
    Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrosteatotic and nonmacrosteatotic grafts respond differently to intermittent hepatic inflow occlusion: Comparison of recipient survival.
    Han S; Choi GS; Kim JM; Kwon JH; Park HW; Kim G; Kwon CH; Gwak MS; Ko JS; Joh JW
    Liver Transpl; 2015 May; 21(5):644-51. PubMed ID: 25690881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury.
    Núñez KG; Frank A; Gonzalez-Rosario J; Galliano G; Bridle K; Crawford D; Seal J; Abbruscato F; Vashistha H; Thevenot PT; Cohen AJ
    PLoS One; 2019; 14(4):e0216242. PubMed ID: 31034519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
    Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
    Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.
    Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA
    Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term outcomes after steatotic liver transplantation.
    Doyle MB; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Brunt EM; Chapman WC
    Arch Surg; 2010 Jul; 145(7):653-60. PubMed ID: 20644128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
    Wan P; Yu X; Xia Q
    Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative intensive care of biliary atresia patients treated with living donor liver transplantation].
    Deng YH; Guo CB; Zhang MM; Li YC
    Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):21-6. PubMed ID: 21429307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.